Angebote zu "Boundaries" (6 Treffer)

Kategorien

Shops

Concise Ketogenic Bible: A No-Fluff Beginner's ...
9,95 € *
ggf. zzgl. Versand

Are you planning on trying ketosis and need all the required information to do it right as a beginner. Then this audiobook is for you. With weight-loss programs in the United States averaging a billion dollars every year, the introduction of nutritional ketosis became expedient to give weight watchers the much required guide to follow. Using ketogenic diets, sportsmen like Lebron James and Tour de France winner Chris Froome pushed the boundaries of what most people thought was physically impossible. Even top health experts and the United States Government have been using ketogenic diets to increase peak physical performance in Navy Seals and NASA astronauts. This sparked curiosity, not only for professional athletes but the general public as well, on the efficacy of ketogenic diets for a healthy lifestyle. The ketogenic diets is one of the most popular diet for treating type 2 diabetes, brain cancer, weight loss and healthy living. Concise Ketogenic Bible is a beginner’s guide that offers a comprehensive look at the ketogenic diet and how it turns your body into a fat-burning machine. The approach is based on the wide range of scientific research that’s been conducted on ketosis and practical tips and advice to effectively enter into ketosis. It provides an exhaustive, science-based view of what it means to follow a ketogenic diet. This is your one-stop shop for the most tested and accurate information on the ketogenic diet and for answers to all your questions. This audiobook also provides you with an easy-to-understand guide on ketosis and how it can help you burn lots of fat within a short period of time. Specifically, it includes action-oriented steps so you can implement everything you learn immediately into your life. It's all about eating the right foods so that your body can quickly and effectively induce ketosis. Once this happens, your body uses fat directly as a source of energy.   1. Language: English. Narrator: Jennifer Sisco. Audio sample: http://samples.audible.de/bk/acx0/115252/bk_acx0_115252_sample.mp3. Digital audiobook in aax.

Anbieter: Audible
Stand: 14.08.2020
Zum Angebot
Living Chronic
71,90 CHF *
ggf. zzgl. Versand

Diabetes, referred to as an epidemic for more than a decade, remains one of our most significant health issues in the twenty-first century. Because self-management is an important component of living with the disease, the biomedical concept of patient agency has long stressed notions of individual responsibility and autonomy. However, dramatic shifts in both health care and cultural practices call for a reassessment of traditional definitions of patient agency. Lora Arduser's Living Chronic: Agency and Expertise in the Rhetoric of Diabetes answers this call with a unique rhetorical examination of one of the most critical issues in contemporary health: how we live and work with being chronic. Through her perceptive analysis of the discourse of both people with diabetes and health care providers, Arduser presents a new model for patient agency-one that advocates for a relational, fluid concept of agency that blurs the boundaries between medical experts and patients. Her thought-provoking use of bodily and rhetorical plasticity crafts a multidimensional picture of patient agency that profoundly affects how rhetorical scholars, people living with chronic illness, and health care providers can forge patient-centered discourse and practices.

Anbieter: Orell Fuessli CH
Stand: 14.08.2020
Zum Angebot
Data Monitoring in Clinical Trials
96,90 CHF *
ggf. zzgl. Versand

Randomized clinical trials are the gold standard for establishing many clinical practice guidelines and are central to evidence based medicine. Obtaining the best evidence through clinical trials must be done within the boundaries of rigorous science and ethical principles. One fundamental principle is that trials should not continue longer than necessary to reach their objectives. Therefore, trials must be monitored for recruitment progress, quality of data, adherence to patient care or prevention standards, and early evidence of benefit or harm. Frequently, a group of external experts, independent from the investigators and trial sponsor, is charged with this monitoring responsibility, especially for safety and early benefit. This group is referred to by various names, such as a data monitoring committee or a data and safety monitoring board. This book, through a series of case studies presented by many distinguished clinical trial experts, illustrates the complexity of this monitoring process. The editors provide an overview of the process and a summary of a multitude of the lessons learned from the cases presented. This book should be useful to anyone serving on a data and safety monitoring board, or planning to do so, for colleagues in academia, industry and governmental agencies, and for teaching students in biostatistics, epidemiology, clinical trials and medical ethics. No other text has as extensive a collection of cases which provide insight into the many issues, often conflicting, that must be examined before recommendations to continue or discontinue a trial can be made. While depth in statistical methods is not required, some familiarity with statistical design and analysis issues in clinical trials is helpful. The cases cover trials which were terminated early for convincing evidence of benefit, or for harmful effects. Cases with complex issues are also included. This series of cases should provide broad background information for potential monitoring committee members and better prepare them for the challenges that may exist in the trials for which they are responsible. 'This book is a must-read for individuals serving on or supporting data monitoring committees as well as statisticians and other disciplines involved in the design and analysis of clinical trials with interim monitoring.' Journal of Biopharmaceutical Sciences, Issue 6, 2006 TOC:From the contents: Assessing Possible Late Treatment Effects Early- The Diabetic Retinopathy Study Experience.- Data and Safety Monitoring in the Beta-Blocker Heart Attack Trial- Early Experiences in Formal Monitoring Methods.- Data Monitoring for the Aspirin Component of the Physicians Health Study- Importance of Secondary Outcomes.- Early Termination of the Stroke Prevention in Atrial Fibrillation I Trial- Protecting Participant Interests in the Face of Scientific Uncertainties and the Cruel Play of Chance.- Early Termination of the Diabetes Control and Complications Trial - Methodologic Issues.- Data Monitoring in the AIDS Clinical Trials Group Study #981- Conflicting Interim Results.- Challenges in Monitoring the Breast Cancer Prevention Trial.- Costantino andTheodore Colton.- Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure.- Potentially High Risk Treatment in High Risk Patients.- Stopping the Randomized Aldactone Evaluation Study Early for Efficacy.- Data Monitoring in the Heart Outcomes Prevention Evaluation and the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events Trials- Avoiding Important Information Loss.

Anbieter: Orell Fuessli CH
Stand: 14.08.2020
Zum Angebot
Living Chronic
39,99 € *
ggf. zzgl. Versand

Diabetes, referred to as an epidemic for more than a decade, remains one of our most significant health issues in the twenty-first century. Because self-management is an important component of living with the disease, the biomedical concept of patient agency has long stressed notions of individual responsibility and autonomy. However, dramatic shifts in both health care and cultural practices call for a reassessment of traditional definitions of patient agency. Lora Arduser's Living Chronic: Agency and Expertise in the Rhetoric of Diabetes answers this call with a unique rhetorical examination of one of the most critical issues in contemporary health: how we live and work with being chronic. Through her perceptive analysis of the discourse of both people with diabetes and health care providers, Arduser presents a new model for patient agency-one that advocates for a relational, fluid concept of agency that blurs the boundaries between medical experts and patients. Her thought-provoking use of bodily and rhetorical plasticity crafts a multidimensional picture of patient agency that profoundly affects how rhetorical scholars, people living with chronic illness, and health care providers can forge patient-centered discourse and practices.

Anbieter: Thalia AT
Stand: 14.08.2020
Zum Angebot
Data Monitoring in Clinical Trials
84,70 € *
ggf. zzgl. Versand

Randomized clinical trials are the gold standard for establishing many clinical practice guidelines and are central to evidence based medicine. Obtaining the best evidence through clinical trials must be done within the boundaries of rigorous science and ethical principles. One fundamental principle is that trials should not continue longer than necessary to reach their objectives. Therefore, trials must be monitored for recruitment progress, quality of data, adherence to patient care or prevention standards, and early evidence of benefit or harm. Frequently, a group of external experts, independent from the investigators and trial sponsor, is charged with this monitoring responsibility, especially for safety and early benefit. This group is referred to by various names, such as a data monitoring committee or a data and safety monitoring board. This book, through a series of case studies presented by many distinguished clinical trial experts, illustrates the complexity of this monitoring process. The editors provide an overview of the process and a summary of a multitude of the lessons learned from the cases presented. This book should be useful to anyone serving on a data and safety monitoring board, or planning to do so, for colleagues in academia, industry and governmental agencies, and for teaching students in biostatistics, epidemiology, clinical trials and medical ethics. No other text has as extensive a collection of cases which provide insight into the many issues, often conflicting, that must be examined before recommendations to continue or discontinue a trial can be made. While depth in statistical methods is not required, some familiarity with statistical design and analysis issues in clinical trials is helpful. The cases cover trials which were terminated early for convincing evidence of benefit, or for harmful effects. Cases with complex issues are also included. This series of cases should provide broad background information for potential monitoring committee members and better prepare them for the challenges that may exist in the trials for which they are responsible. 'This book is a must-read for individuals serving on or supporting data monitoring committees as well as statisticians and other disciplines involved in the design and analysis of clinical trials with interim monitoring.' Journal of Biopharmaceutical Sciences, Issue 6, 2006 TOC:From the contents: Assessing Possible Late Treatment Effects Early- The Diabetic Retinopathy Study Experience.- Data and Safety Monitoring in the Beta-Blocker Heart Attack Trial- Early Experiences in Formal Monitoring Methods.- Data Monitoring for the Aspirin Component of the Physicians Health Study- Importance of Secondary Outcomes.- Early Termination of the Stroke Prevention in Atrial Fibrillation I Trial- Protecting Participant Interests in the Face of Scientific Uncertainties and the Cruel Play of Chance.- Early Termination of the Diabetes Control and Complications Trial - Methodologic Issues.- Data Monitoring in the AIDS Clinical Trials Group Study #981- Conflicting Interim Results.- Challenges in Monitoring the Breast Cancer Prevention Trial.- Costantino andTheodore Colton.- Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure.- Potentially High Risk Treatment in High Risk Patients.- Stopping the Randomized Aldactone Evaluation Study Early for Efficacy.- Data Monitoring in the Heart Outcomes Prevention Evaluation and the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events Trials- Avoiding Important Information Loss.

Anbieter: Thalia AT
Stand: 14.08.2020
Zum Angebot